Responses
Abstracts Accepted for Publication
Rheumatoid arthritis - other biologic treatment
AB0489 Leucine-Rich Alpha-2 Glycoprotein (LRG) as a Potential Disease Activity Marker During IL-6 Blockade in Autoimmune Arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.